Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-seasonal sublingual grass-specific immunotherapy for allergic rhinoconjunctivitis
2008-004388-20Phase 4Completed
- Sponsor
- Policlinico Gemelli
- Start
- Jul 2008
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, double-blind trial of Oralair in allergic rhinoconjunctivitis (ARC), allergic rhinitis (AR), chronic bronchitis (CB) and 2 more (2 arms), sponsored by Policlinico Gemelli. Primary endpoint: Abatement of symptoms. Started Jul 2008; status: completed.
02
Drugs
Oralair
03
Conditions
allergic rhinoconjunctivitis (ARC)allergic rhinitis (AR)chronic bronchitis (CB)rhinosinusitisallergy
Beyond the preview
Go deeper on 2008-004388-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004388-20.